Marizyme, Inc.
MRZM · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | -78.2% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -566.4% | -77.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $1 | $1 | $7 |
| SG&A Expenses | $1 | $1 | $1 | $8 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $1 |
| Other Operating Expenses | $0 | $0 | $0 | $14 |
| Operating Expenses | $1 | $2 | $1 | $22 |
| Operating Income | -$1 | -$2 | -$1 | -$22 |
| % Margin | – | – | -4,175.9% | -14,806.2% |
| Other Income/Exp. Net | -$1 | -$2 | -$5 | $13 |
| Pre-Tax Income | -$2 | -$4 | -$6 | -$10 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2 | -$4 | -$6 | -$10 |
| % Margin | – | – | -18,949.9% | -6,486.4% |
| EPS | -0.015 | -0.031 | -0.047 | -0.19 |
| % Growth | 51.8% | 34.5% | 75.2% | – |
| EPS Diluted | -0.015 | -0.031 | -0.047 | -0.19 |
| Weighted Avg Shares Out | 132 | 132 | 132 | 45 |
| Weighted Avg Shares Out Dil | 132 | 132 | 132 | 45 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $3 | $4 | $8 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$1 | -$2 | -$8 |
| % Margin | – | – | -5,646% | -5,205.7% |